Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

This study has been completed.
National Institute of Allergy and Infectious Diseases (NIAID)
EuroVacc Foundation
Information provided by (Responsible Party):
HIV Vaccine Trials Network Identifier:
First received: August 17, 2009
Last updated: September 4, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by HIV Vaccine Trials Network

Publications automatically indexed to this study by Identifier (NCT Number):